OraSure Technologies
OraSure Technologies Wins $109M DoD Contract to Ramp Up Rapid COVID-19 Tests
The funding is part of a national pandemic preparedness plan and will enable the firm to scale manufacturing of rapid antigen tests.
OraSure Technologies Nabs $13.6M BARDA Funding
The funding will support OraSure's efforts to obtain 510(k) clearance and CLIA waiver for the InteliSwab rapid SARS-CoV-2 antigen test.
US Department of Defense Awards $647M to Procure Rapid Antigen Tests
The US Department of Defense will procure rapid antigen tests from OraSure Technologies, Quidel, Abbott, and Intrivo.
OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer
The firm's stock price rose as much as nearly 12 percent on Monday following a report saying that it had rejected a takeover bid from Quidel.
OraSure Technologies Gets FDA Emergency Use Authorization for Home-Use COVID-19 Antigen Tests
The firm said that its InteliSwab point-of-care antigen tests have received FDA authorization for over-the-counter, professional, and prescription use.
May 5, 2021
OraSure Technologies Q1 Revenues Jump 85 Percent
Mar 3, 2021
Dec 3, 2020
Will US Ever Get to Mass Testing for COVID-19?
Nov 4, 2020
OraSure Q3 Revenues Jump 33 Percent
Aug 7, 2020